Noteless Raises €3.5M To Ease Doctors’ Administrative Work

The round was led by new investor Redstone, with existing backers Futurum Ventures and Farvatn Venture continuing their support.

Medical documentation has long posed a challenge for clinicians, consuming hours that could otherwise be spent on patient care or professional development. Excessive administrative workload contributes to burnout, lower job satisfaction, and staff attrition.

Noteless tackles this problem with an AI-powered clinical documentation tool that generates medical notes in real time during consultations.

Read Also - Future Energy Ventures Raises €205M Fund II To Boost European EnergyTech Investments

Founded in October 2023, the company leverages advanced speech recognition and natural language processing to help clinicians save time, reduce administrative burden, and maintain high-quality patient care.

Since launching its first product in June 2024, Noteless has seen its paying customer base grow by over 360% year-to-date.

William Vossgård, CEO and co-founder of Noteless, highlighted strong Nordic adoption, with over one in four general practitioners in Norway and one in seven in Denmark now using the platform.

Clinicians tell us we’re giving them back up to two hours a day, time they can spend with patients or on their own wellbeing, Vossgård said.

Adoption is expanding beyond general practice, with specialists, physiotherapists, and psychologists using Noteless to streamline documentation, enhance patient care, and free up time for higher-value tasks. The company plans to use the new funding to extend its impact to clinicians across Europe.

About Noteless

Noteless is a Norwegian healthtech company creating AI solutions that reduce administrative time for healthcare professionals. Its ambient medical scribe transcribes consultations and generates structured notes in seconds. Used in over 3 million consultations across 500+ organizations, Noteless supports multiple professions and languages, helping clinicians focus on patient care.